Related Experiment Video
Updated: Jul 15, 2025

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Determining the antiviral mechanism of MARCH2
Supawadee Umthong1,2, Uddhav Timilsina1, Mary D'Angelo1
1Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States.
Abstract:
Membrane-associated RING-CH (MARCH) 2 protein is a member of the MARCH protein family of RING-CH finger E3 ubiquitin ligases that have important functions in regulating the levels of proteins found on the cell surface. MARCH1, 2 and 8 inhibit HIV-1 infection by preventing the incorporation of the envelope glycoproteins in nascent virions. However, a better understanding on the mechanism utilized by MARCH proteins to restrict HIV-1 is needed. In this report, we identify an amino acid in human MARCH2, that is absent in mouse MARCH2, critical for its antiretroviral function. Moreover, we map the domains of human MARCH2 critical for restricting as well as binding to the HIV-1 envelope glycoproteins. Our findings reveal important new aspects of the antiviral mechanism utilized by human MARCH2 to restrict HIV-1 that have potential implications to all MARCH proteins with antiviral functions.
Insights
Human Membrane-associated RING-CH (MARCH) 2 protein restricts HIV-1 by preventing viral envelope glycoprotein incorporation. A specific amino acid and key domains in human MARCH2 are critical for this antiretroviral function.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Membrane-associated RING-CH (MARCH) 2 is an E3 ubiquitin ligase regulating cell surface proteins.
- MARCH proteins, including MARCH1, 2, and 8, inhibit HIV-1 by blocking envelope glycoprotein incorporation into virions.
- The precise mechanism of MARCH protein-mediated HIV-1 restriction requires further elucidation.
Approach:
- Identified a specific amino acid in human MARCH2, absent in mouse MARCH2, essential for its antiretroviral activity.
- Mapped the domains of human MARCH2 responsible for HIV-1 restriction and envelope glycoprotein binding.
- Investigated the molecular interactions between human MARCH2 and HIV-1 envelope glycoproteins.
Key Points:
- A single amino acid difference between human and mouse MARCH2 is critical for antiretroviral function.
- Specific domains within human MARCH2 mediate both the restriction of HIV-1 and binding to its envelope glycoproteins.
- This study provides a detailed mechanistic understanding of human MARCH2's antiviral action against HIV-1.
Conclusions:
- Human MARCH2 possesses a specific amino acid crucial for its ability to restrict HIV-1.
- The identified domains of human MARCH2 are key to its antiretroviral mechanism and interaction with viral components.
- These findings advance our understanding of MARCH protein antiviral functions and have implications for broader MARCH protein research.
Related Concept Videos
Subviral Agents
Mechanisms of Retrovirus-induced Cancers
Retroviruses
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Leaky Scanning

